-SEC Filing
Crude Oil Down Over 1%; Deciphera Pharmaceuticals Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.2% on Monday. Following the…
Related Posts
Morgan Stanley Downgrades Centessa Pharmaceuticals to Underweight, Lowers Price Target to $5
Morgan Stanley analyst Matthew Harrison downgrades Centessa Pharmaceuticals (NASDAQ:CNTA) from Overweight to Underweight and lowers the price target from $10 to $5.
Tesla Big Winner Of UAW Strike, Rivian Stands Tall Among Upstarts, Nikola CEO Calms Nerves And More: Biggest EV Stories Of The Week
EV socks closed mostly higher this week amid the broader market strength and market leader Tesla broke out of a recent trading range.
Cowen & Co. Maintains Market Perform on Emergent BioSolutions, Lowers Price Target to $29
Cowen & Co. analyst Boris Peaker maintains Emergent BioSolutions (NYSE:EBS) with a Market Perform and lowers the price target from $30 to $29.